EP2877165

ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    29.7.2013
  • :
    5.9.2018
  • :
    13745810.5
  • :
    28.7.2033
  • :
    ENHANCED BRAIN BIOAVAILABILITY OF GALANTAMINE BY SELECTED FORMULATIONS AND TRANSMUCOSAL ADMINISTRATION OF LIPOPHILIC PRODRUGS

29.7.2013
5.9.2018
  • :
    Neurodyn Life Sciences Inc.
  • :
    Suite 508 NRC-INH 550 University Ave.,, Charlottetown, P.E.I., C1A 4P3, CA
  • :
    MAELICKE, Alfred
  • :
    Nieder-Olm, DE
  • :
    201261676348 P
  • :
    27.7.2012
  • :
    US
  • :
    12178187
  • :
    27.7.2012
  • :
    EP
  • :
    EP2013065880
  • :
    29.7.2013
  • :
    A61K 31/55, A61K 31/00, A61P 25/28, A61K 9/00, A61K 9/107, A61K 9/14, A61K 9/20, A61K 9/28